| 23-May-13 01:55PM | Why This Obesity Drug Is the Sector's Best Bet at Motley Fool |
| 01:20PM | Arena Buyout More 'Highly Probable' Than MannKind at Seeking Alpha |
| 22-May-13 11:06PM | Why Doctors Can Prescribe Arena's Belviq For Off Label Uses Without Worrying About Legal Liability at Seeking Alpha |
| 08:56PM | 3 Pipeline Obesity Treatments You Should Watch at Motley Fool |
| 03:19AM | Arena Pharmaceuticals - Out To Launch Or Out To Lunch? at Seeking Alpha |
| 21-May-13 06:56AM | The Facebook Effect On Arena's Belviq Sales And Why It Will Ultimately Dwarf Anything Eisai Does at Seeking Alpha |
| 20-May-13 02:06PM | The 9 Most Obese Countries in the World at Motley Fool |
| 03:05AM | Arena NOLs Will Come Into Play Soon at Seeking Alpha |
| 19-May-13 09:41AM | Vivus Taps Into More Cash at Seeking Alpha |
| 18-May-13 08:01AM | 25 Belt-Busting Obesity Facts at Motley Fool |
| 17-May-13 01:04PM | ARENA PHARMACEUTICALS INC Financials EDGAR Online Financials |
| 02:01AM | Arena Outlines Belviq Launch And Goals at Seeking Alpha |
| 15-May-13 07:04PM | Weight Loss Isn't Just for Looking Good Anymore at Motley Fool |
| 10:18AM | Vivus - Mild Drama Continues at Seeking Alpha |
| 08:42AM | Will Obesity Drugs Gain Soon? at Motley Fool |
| 14-May-13 05:49AM | Looking at Arena Following Sell-Off at Motley Fool |
| 05:42AM | Vivus Starting To Gain The Advantage Over Arena at Seeking Alpha |
| 01:16AM | Shorting Arena Is Not a Good Idea Now at Motley Fool |
| 01:08AM | Arena, Vivus, And Off-Label Prescriptions at Seeking Alpha |
| 11-May-13 03:00PM | Deal Discussions Distract From Disappointing Obesity Drug Sales at Motley Fool |
| 09:53AM | Why Does Arena's Obesity Drug Have Abuse Potential? at Forbes |
| 10-May-13 02:31PM | Belviq's Sales Will Disappoint: Demographics Matter at Seeking Alpha |
| 08:00AM | Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch 2013 Health Care Conference PR Newswire |
| 02:07AM | Vivus Shifting Gears at Seeking Alpha |
| 12:21AM | For Arena, Sales Is Key at Seeking Alpha |
| 09-May-13 08:16PM | Is the Golden Age of Blockbusters Over? at Motley Fool |
| 03:20PM | ARNA Sheds Light on Belviq Launch Zacks |
| 10:11AM | ARENA PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 08:35AM | VIVUS Reports Wider Loss Zacks |
| 07:12AM | Obesity Drug Demand Still Low at Motley Fool |
| 03:46AM | Recent Noteworthy Institutional 5% Ownership Filings In Healthcare Sector at Seeking Alpha |
| 08-May-13 03:10PM | Vivus, Obesity Drug Stocks Finally Get Some Good News at Investor's Business Daily |
| 01:41PM | Will The Prescription Diet Pill Market Finally Bulk Up? at Forbes |
| 08:54AM | Vivus reports weak sales of diet pill Qsymia at Reuters |
| 08:27AM | Today's Market News To Trade On: 5 Stocks Moving On News at Seeking Alpha |
| 07:50AM | Vivus reports weak sales of diet pill Qsymia at Reuters |
| 07-May-13 04:54PM | On The Fly: Closing Wrap at theflyonthewall.com +10.90% |
| 03:38PM | Top Small-Cap Biotech Stocks Being Accumulated By Large Fund Managers at Seeking Alpha |
| 03:32PM | InPlay: Arena Pharm provides update on upcoming U.S. launch of BELVIQ (lorcaserin HCl); to receive $65 mln in milestone payments from Eisai Briefing.com |
| 03:30PM | Arena Pharmaceuticals Provides Update on Upcoming US Launch of BELVIQ® (lorcaserin HCl) for Chronic Weight Management PR Newswire |
| 03:05PM | Arena Gets Long Awaited DEA Scheduling at Seeking Alpha |
| 02:16PM | Arena climbs after DEA takes action on anti-obesity drug at theflyonthewall.com |
| 01:42PM | The Long Wait for This Obesity Drug Is Almost Over at Motley Fool |
| 12:58PM | On The Fly: Midday Wrap at theflyonthewall.com |
| 12:38PM | Arenas FDA-Approved Weight Loss Pill Clears DEA Hurdle at Bloomberg |
| 12:10PM | Improving Prospects of This Obesity Bet at Motley Fool |
| 11:53AM | Happy Day for Arena Bulls, Bears as Belviq Launch Finally Arrives at TheStreet |
| 06:29AM | Barron's 500: America's Top Companies Leaves One Wishing For A Thicker Wallet at Seeking Alpha |
| 06:29AM | Barron's 500: America's Top Companies Leave One Wishing For A Thicker Wallet at Seeking Alpha |
| 01:25AM | Arena And Vivus Weaken On Poor Obesity Drug Prospects In Europe at Seeking Alpha |
| 06-May-13 06:02PM | Nasdaq stocks posting largest percentage decreases AP |
| 01:27PM | Nasdaq stocks posting largest percentage decreases AP |
| 10:40AM | Arena Pharma Narrows Loss Zacks |
| 08:06AM | Today's Market News To Trade On: 5 Stocks Moving On News at Seeking Alpha |
| 05-May-13 03:00PM | Are Obesity Drugs a Lost Cause in Europe? at Motley Fool |
| 04-May-13 05:22PM | 1 Winner and 4 Losers from This Weeks Earnings Storm at Wall St. Cheat Sheet |
| 04:05PM | This Week in Biotech at Motley Fool |
| 08:00AM | U.S.-Approved Obesity Drug Derailed in EU at Motley Fool |
| 03-May-13 06:06PM | Nasdaq stocks posting largest percentage decreases AP -9.17% |
| 01:43PM | Why Arena Pharmaceuticals Shares Slimmed Down at Motley Fool |
| 01:16PM | Sprint Opposed By Mount Kellett Alliance and 2 Other Hot Stocks To Watch at Wall St. Cheat Sheet |
| 01:04PM | Analysts: Estimates on AIG Will Increase and 3 Other Research Notes to Browse at Wall St. Cheat Sheet |
| 10:42AM | Stocks Rocket On Jobs Data; Fleetcor, Bonanza Creek Soar at Investor's Business Daily |
| 09:54AM | Arena Stock Gaps Down On Today's Open (ARNA) at TheStreet |
| 09:16AM | Earnings Roundup: Arena Pharmaceuticals, Kraft, ADP at Barrons.com |
| 08:50AM | Today's Market News To Trade On: 5 Stocks Moving On News at Seeking Alpha |
| 08:31AM | Bears hammer LinkedIn on outlook optionMONSTER |
| 01-May-13 09:11AM | Vivus And Anti-Obesity Sector Benefit From New Insurance Deal at Seeking Alpha |
| 08:52AM | 4 Bio Stocks to Buy Today at Motley Fool |
| 30-Apr-13 03:00PM | U.S. Stock Options With Biggest Changes in Implied Volatility at Bloomberg |
| 02:37PM | Investing in Biotech Companies? Know These Names! at Motley Fool |
| 11:31AM | Finding Value in Biotech Pipelines: An Expert Analyst Discusses the Disconnect in the Biotech Sector in How Companies are Valued Relative to What They Can Do Wall Street Transcript |
| 11:15AM | Have Drugmakers Found the Panacea for Obesity? (Part I) at Motley Fool |
| 10:45AM | Stocks Down In Rising Trade; Nuance Communications Falls at Investor's Business Daily |
| 10:45AM | Stocks Down In Rising Trade; Nuance Communications Crumbles at Investor's Business Daily |
| 07:10AM | 3 Biotech Companies Ripe for a Takeover at Motley Fool |
| 07:07AM | Q1 2013 Arena Pharmaceuticals Earnings Release - After Market Close CCBN |
| 29-Apr-13 11:16AM | Have Drugmakers Found the Panacea for Obesity? (Part II) at Motley Fool |
| 11:01AM | Wall Street Transcript Interview with Brian Skorney, Senior Analyst at Robert W. Baird & Co.: FDA Approvals Accelerate and Opportunities Arise in Hepatitis C Market Wall Street Transcript |
| 01:47AM | Arena To Offer Quarterly Results - What Investors Need To Hear at Seeking Alpha |
| 27-Apr-13 05:36PM | Exciting Catalysts Approaching for This Bet at Motley Fool |
| 26-Apr-13 08:00AM | Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, May 2 PR Newswire |
| 03:41AM | Arena Short Story Getting Interesting at Seeking Alpha |
| 25-Apr-13 12:20PM | Key group's guidelines seen positive for obesity drug makers at theflyonthewall.com +5.84% |
| 24-Apr-13 03:02PM | These Obesity Stock Plays Could Offer 'Blockbuster' Drug Potential at Seeking Alpha |
| 05:47AM | Arena Faces A Convergence Of DEA And European Decisions at Seeking Alpha |
| 23-Apr-13 04:22PM | Anti-Obesity Stocks Are Attractively Priced at Motley Fool |
| 19-Apr-13 12:55PM | Do These Factors Support Arena Pharmaceuticals? at Wall St. Cheat Sheet |
| 10:45AM | Vivus Seeing Traction With Qsymia at Seeking Alpha |
| 09:39AM | Stocks to Know for the Obesity Epidemic at Motley Fool |
| 07:12AM | The Zacks Analyst Blog Highlights: Microsoft, VIVUS, Arena Pharmaceuticals, Orexigen Therapeutics and UCB Zacks |
| 18-Apr-13 06:34PM | Obesity and Weight Management: How Much Weight Loss is Actually Necessary? at Motley Fool |
| 06:30PM | Expanded Access for VIVUS' Qsymia Zacks |
| 04:22PM | These 4 'High-Potential' Biotech Stocks Could Outperform In 2013 at Seeking Alpha |
| 17-Apr-13 12:30AM | Vivus Gets Restrictions Loosened at Seeking Alpha |
| 16-Apr-13 04:11PM | FDA Makes Obesity Drug Available to More Americans at Motley Fool |
| 03:00PM | U.S. Stock Options With Biggest Changes in Implied Volatility at Bloomberg |
| 02:44PM | FDA Loosens Restrictions on Vivus Weight-Loss Pill at TheStreet |
| 07:55AM | AVEO Poised To Move Higher Before FDA Adcomm Catalyst, Obamacare And Platform Potential at Seeking Alpha |
| 15-Apr-13 07:44PM | America's Hidden Obesity Epidemic at Motley Fool |
